Oral potassium chloride and amiloride in hydrochlorothiazide-induced potassium loss.
To compare the effect of amiloride with that of oral potassium chloride (KCl) in hypokalemia, metabolic balance studies were carried out in hospitalized subjects with mild hypertension without edema who developed negative potassium balance after 4 days on hydrochlorothiazide (HCTZ). Subjects' diets contained measured amounts of sodium and potassium. While HCTZ treatment continued, oral preparations of either KCl solution or amiloride was added for 5 additional days. Potassium balance in the KCl-treated group further decreased by -44.9 +/- 32.3 mEq K+, while subjects on amiloride went into positive balance that averaged +51.7 +/- 24.1 mEq K+. Hypokalemia after HCTZ did not respond to KCl, while K+ levels rose from 3.32 +/- 0.22 to 3.67 +/- 0.26 mEq/l after amiloride.
D000284:Administration, Oral; D000328:Adult; D000450:Aldosterone / Q000097:blood; D000584:Amiloride / Q000378:metabolism / Q000627:therapeutic use*; D001682:Biological Availability; D003404:Creatinine / Q000097:blood; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D006852:Hydrochlorothiazide / Q000009:adverse effects* / Q000627:therapeutic use; D006973:Hypertension / Q000188:drug therapy; D007008:Hypokalemia / Q000139:chemically induced / Q000188:drug therapy*; D007700:Kinetics; D008297:Male; D008875:Middle Aged; D011188:Potassium / Q000097:blood / Q000378:metabolism / Q000627:therapeutic use*; D011719:Pyrazines / Q000627:therapeutic use*; D012964:Sodium / Q000097:blood / Q000652:urine
D011719:Pyrazines; D006852:Hydrochlorothiazide; D000450:Aldosterone; D000584:Amiloride; D012964:Sodium; D003404:Creatinine; D011188:Potassium